Skip to content

Three Quick Facts: Ryanair, AstraZeneca and BT

Three Quick Facts: Ryanair, AstraZeneca and BT

Ryanair has released its traffic figures for January this morning and despite the overhang over those pre-Christmas strikes, passengers still flock to the low cost airline. An extra 500,000 passengers flew with the airline compared to the same month last year, but much of the uplift has been driven by lower fares. The extent of the cuts isn’t revealed in these figures however – just how far are margins being squeezed, and how will other airlines react this morning.



Full year results from the pharmaceuticals giant AstraZeneca have been published but it seems as if there’s little to inspire investors here. The company is attempting to turn a corner and has a reasonable product development pipeline but revenues for the year slipped as expected by 2%. The company is however expecting to see some sales growth return for the next financial year and the dividend payment remains unchanged.



British Telecom published third quarter results this morning, with revenues posting a slight fall from the 2016 figure. The company was keen to push the fact viewing of its BT Sport channel was up 23% on a year ago, but with no details over revenues here, it’s difficult to tell just how much of the audience is actually paying for the service.



Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

aberdeen
WisdomTree
ARK
Plus500
CMC Markets
Back To Top